254 related articles for article (PubMed ID: 20159941)
1. Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments.
Rochdi MD; Vargas GA; Carpentier E; Oligny-Longpré G; Chen S; Kovoor A; Gitelman SE; Rosenthal SM; von Zastrow M; Bouvier M
Mol Pharmacol; 2010 May; 77(5):836-45. PubMed ID: 20159941
[TBL] [Abstract][Full Text] [Related]
2. Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis.
Kocan M; See HB; Sampaio NG; Eidne KA; Feldman BJ; Pfleger KD
Mol Endocrinol; 2009 Apr; 23(4):559-71. PubMed ID: 19179480
[TBL] [Abstract][Full Text] [Related]
3. Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).
Armstrong SP; Seeber RM; Ayoub MA; Feldman BJ; Pfleger KD
PLoS One; 2013; 8(6):e65885. PubMed ID: 23762448
[TBL] [Abstract][Full Text] [Related]
4. Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis.
Erdélyi LS; Mann WA; Morris-Rosendahl DJ; Groß U; Nagel M; Várnai P; Balla A; Hunyady L
Kidney Int; 2015 Nov; 88(5):1070-8. PubMed ID: 26131744
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients.
Gitelman SE; Feldman BJ; Rosenthal SM
Am J Med; 2006 Jul; 119(7 Suppl 1):S54-8. PubMed ID: 16843086
[TBL] [Abstract][Full Text] [Related]
6. Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside.
Vandergheynst F; Pradier O; Beukinga I; Kornreich A; Vassart G; Decaux G
Eur J Clin Invest; 2012 Mar; 42(3):254-9. PubMed ID: 21834801
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of an activating F229V substitution in the V2 vasopressin receptor in an infant with NSIAD.
Carpentier E; Greenbaum LA; Rochdi D; Abrol R; Goddard WA; Bichet DG; Bouvier M
J Am Soc Nephrol; 2012 Oct; 23(10):1635-40. PubMed ID: 22956819
[TBL] [Abstract][Full Text] [Related]
8. Mutations of Vasopressin Receptor 2 Including Novel L312S Have Differential Effects on Trafficking.
Tiulpakov A; White CW; Abhayawardana RS; See HB; Chan AS; Seeber RM; Heng JI; Dedov I; Pavlos NJ; Pfleger KD
Mol Endocrinol; 2016 Aug; 30(8):889-904. PubMed ID: 27355191
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin receptor 2 mutations in the nephrogenic syndrome of inappropriate antidiuresis show different mechanisms of constitutive activation for G protein coupled receptors.
Vezzi V; Ambrosio C; Grò MC; Molinari P; Süral G; Costa T; Onaran HO; Cotecchia S
Sci Rep; 2020 Jun; 10(1):9111. PubMed ID: 32499611
[TBL] [Abstract][Full Text] [Related]
10. The Vasopressin Receptor 2 Mutant R137L Linked to the Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD) Signals through an Alternative Pathway that Increases AQP2 Membrane Targeting Independently of S256 Phosphorylation.
Ranieri M; Venneri M; Pellegrino T; Centrone M; Di Mise A; Cotecchia S; Tamma G; Valenti G
Cells; 2020 May; 9(6):. PubMed ID: 32486031
[TBL] [Abstract][Full Text] [Related]
11. V2 vasopressin receptor mutations.
Makita N; Manaka K; Sato J; Iiri T
Vitam Horm; 2020; 113():79-99. PubMed ID: 32138955
[TBL] [Abstract][Full Text] [Related]
12. Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059.
Bernier V; Lagacé M; Lonergan M; Arthus MF; Bichet DG; Bouvier M
Mol Endocrinol; 2004 Aug; 18(8):2074-84. PubMed ID: 15166253
[TBL] [Abstract][Full Text] [Related]
13. Gain-of-function mutations of the V2 vasopressin receptor in nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a cell-based assay to assess constitutive water reabsorption.
Ranieri M; Tamma G; Pellegrino T; Vezzi V; Ambrosio C; Grò C; Di Mise A; Costa T; Valenti G; Cotecchia S
Pflugers Arch; 2019 Oct; 471(10):1291-1304. PubMed ID: 31486901
[TBL] [Abstract][Full Text] [Related]
14. [Nephrogenic syndrome of inappropriate antidiuresis].
Nawal B; Izzedine H; Haddiya I; Bentata Y
Pan Afr Med J; 2019; 32():210. PubMed ID: 31312322
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction.
Rosenthal SM; Feldman BJ; Vargas GA; Gitelman SE
Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():66-70. PubMed ID: 17261972
[TBL] [Abstract][Full Text] [Related]
16. Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus.
Barak LS; Oakley RH; Laporte SA; Caron MG
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):93-8. PubMed ID: 11134505
[TBL] [Abstract][Full Text] [Related]
17. [Vasopressin V2 receptor-related pathologies: congenital nephrogenic diabetes insipidus and nephrogenic syndrome of inappropiate antidiuresis].
Morin D
Nephrol Ther; 2014 Dec; 10(7):538-46. PubMed ID: 25449762
[TBL] [Abstract][Full Text] [Related]
18. Novel signalling pathways in nephrogenic syndrome of inappropriate antidiuresis: functional implication of site-specific AQP2 phosphorylation.
Venneri M; Vezzi V; Di Mise A; Ranieri M; Centrone M; Tamma G; Nejsum LN; Valenti G
J Physiol; 2023 Feb; ():. PubMed ID: 36823952
[TBL] [Abstract][Full Text] [Related]
19. Nephrogenic syndrome of inappropriate antidiuresis - An ethnically, genetically and phenotypically diverse disorder: First report in a Chinese adult and review of published cases.
Tong HF; Leung MTS; Chan CHT; Cheung HN; Mak WLT; Chen PLS
Clin Chim Acta; 2021 Aug; 519():214-219. PubMed ID: 33984325
[TBL] [Abstract][Full Text] [Related]
20. Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.
Ranadive SA; Ersoy B; Favre H; Cheung CC; Rosenthal SM; Miller WL; Vaisse C
Clin Endocrinol (Oxf); 2009 Sep; 71(3):388-93. PubMed ID: 19170711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
